Testing the effectiveness of a social prescription and virtual patient information in increasing tertiary prevention among cancer patients

Testing the effectiveness of a social prescription and virtual patient information in increasing tertiary prevention among cancer patients - ESPRIT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00033771

Enrollment

Registered

2024-03-20

Start date

2024-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Patients

Interventions

Group 1: Usual care and social prescription delivered during the consultation with treating physician Group 2: Usual care and virtual patient information delivered within the consultation with treatin

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: The study will include German speaking adult patients (aged =18 years) attending medical oncology units at the participating hospital, diagnosed with early-stage or advanced cancer (i. e., cancer stages I to IV) no more than 6 months ago, who have an expected survival of at least two years and will have provided written informed consent. Support persons will also be included if they are German speaking, aged =18 years and nominated by the patient as someone helping them cope with their cancer through support, encouragement and communication, and will have provided written informed consent.

Exclusion criteria

Exclusion criteria: Key exclusion criteria involve inability to complete surveys or interviews independently (e. g., speech, vigilance).

Design outcomes

Primary

Measure	Time frame
(1) Uptake of physical activity of cancer patients (measured using accelerometers within 4 weeks); (2) Uptake of participation in social activities and psychosocial support (measured with the social activity log and self-report on use of psychosocial support); Time of data collection: Baseline, Follow-up after 3, 6, 12 months	—

Secondary

Measure	Time frame
(3) Quality of life (measured using EORTC QLQ-C15-PAL); (4) Knowledge of the benefits of physical activity and psychosocial support (measured using self-designed questions); (5) Self-efficacy (measured using CBI-B-D); (6) Cost-effectiveness (7) Time spent in the consultation (8) Potential implementation barriers and enablers of the intervention (interviews) Time of data collection: Baseline, Follow-up after 3, 6, 12 months	—

Measure

Time frame

(3) Quality of life (measured using EORTC QLQ-C15-PAL); (4) Knowledge of the benefits of physical activity and psychosocial support (measured using self-designed questions); (5) Self-efficacy (measured using CBI-B-D); (6) Cost-effectiveness (7) Time spent in the consultation (8) Potential implementation barriers and enablers of the intervention (interviews) Time of data collection: Baseline, Follow-up after 3, 6, 12 months

—

Countries

Germany

Contacts

Public ContactLisa Boyer

Universität Regensburg

lisa.boyer@ukr.de0941 944 5227

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026